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A B S T R A C T
One hundred and thirty-one patients on long-term hemodialysis were examined for the presence of clinical symptoms
and signs, and for the effects of dialytic age, age and sex on uremic neuropathy. According to dialysis age, the patients
were divided into three subgroups: low dialysis age, <5 years of dialysis (n=58); intermediate dialysis age, 5-10 years of
hemodialysis (n=39); and high dialysis age, >10 years of dialysis (n=34). Two patient subgroups were differentiated ac-
cording to mean age of 53.2 years: younger (n=57) and older (n=74). Clinical grading of uremic neuropathy was based
on Nielsen’s criteria. The most common symptoms were restless legs syndrome (47%) and cramps (51%). Sensory symp-
toms were less common in patients on long-term hemodialysis, most common of them being paresthesia (29%) and burn-
ing feet syndrome (28%). Abnormal Achilles reflex (53%) and impaired vibration sense (59%) were the most common clin-
ical signs. Clinically manifested uremic neuropathy was present in more than 80% of all study patients, i.e. mild in 41%,
and moderate to severe forms of uremic neuropathy according to Nielsen’s criteria in 39%. There was no evident effect of
dialytic age and sex on the clinical course of uremic neuropathy, however, there was a clear impact of age. It is concluded
that long-term hemodialysis does not influence the clinical course of uremic neuropathy unlike evident deterioration of
electroneurophysiologic findings.
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Introduction
A great number of patients on long-term hemodialysis
have different forms of clinically manifested uremic neu-
ropathy (60–75%). The incidence of uremic neuropathy,
and the prevalence of some symptoms and signs mostly
vary from study to study1–6. Most studies dealing with
the issue included patients hemodialyzed for 1 to 2 years.
Also, there is evidence for dissociation between the sym-
ptoms and signs of neuropathy as well as between the
clinical signs and electrophysiologic findings7–9. Some of
these studies emphasize that long-term dialytic treat-
ment does not influence the clinical course as it does lead
to worsening of electrophysiologic findings. The purpose
of this study was to assess the effect of long-term dialysis
on the clinical course of uremic neuropathy, to evaluate
the impact of age and sex, and eventually to compare the
clinical and electrophysiologic findings. With these aims
in mind, a group of 131 patients dialyzed for more than
10 years were included in the study.
Subjects and Methods
One hundred and thirty-one patients on long-term
hemodialysis at Department of Nephrology and Dialysis,
General Hospital »Sveti Duh«, were included in the
study. Patients with diabetes mellitus, chronic alcohol-
ism, exposure to toxic drugs, collagen vascular disease,
amyloidosis and sarcoidosis, patients previously treated
with peritoneal dialysis and those who had rejected
transplantation were excluded from the study. In the
771
Received for publication June 20, 2008
group of 131 hemodialyzed patients the mean age was
53.12 ± 13.2, and mean dialytic age 6.62 ± 5.0 years.
Other features of the study patients are shown in Table 1.
Study patients were divided into two subgroups ac-
cording to mean age (younger and older), and into three
subgroups according to mean dialysis age: low dialysis
age (LDA), <5 years on hemodialysis (n=58); intermedi-
ate dialysis age (IDA), 5–10 years on hemodialysis (n=39);
and high dialysis age (HDA), >10 years on hemodialysis
(n=34). There was no significant age difference between
different dialysis age groups. Similarly, there was no sig-
nificant difference in dialysis age between the two age
subgroups of hemodyalized patients (Table 1).
Clinical bedside examination was performed in each
individual patient. Symptoms and clinical signs relevant
for uremic neuropathy were tested as previously de-
scribed (Nielsen 1). Clinical grading of uremic neuropa-
thy was established according to Nielsen’s criteria: group
I, no neuropathy; group II, mild neuropathy; and group
III, moderate and severe neuropathy.
c2-test and t-test were used on statistical analysis.
Results
Many patients on long-term hemodialysis have some
symptoms and signs of uremic neuropathy. More than
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TABLE 1
CHARACTERISTICS OF HEMODIALYSED PATIENTS (N=131)
Subjects Age (yrs)
Dialysis
age (yrs)
(n) (%) (c±SD) (c±SD)
Sex
Female 65 49.60
Male 66 50.40
Age
(yrs)
Younger
(< 53.2)
57 44 40.3 ± 9.4 7.25 ± 5.1
Older
(³ 53.2)
74 56 62.32 ± 5.9 6.18 ± 5.0
Dialysis
age (yrs)
<5 58 44 54.34 ± 15.7 2.05 ± 1.3
5–10 39 30 53.30 ± 11.5 7.08 ± 1.2
³ 10 34 26 51.06 ± 9.6 13.8 ± 2.4
TABLE 2
CLINICAL FINDINGS IN PATIENTS ON LONG-TERM HEMODIALYSIS
Parameter
Total
n=131 (%)
Female
n=65 (%)
Malem
n=66 (%)
p
Younger
n=57 (%)
Older
n=74 (%)
p
Symptom
Restless legs
Cramps (legs)
Cramps (arms)
Muscular weakness (legs)
Muscular weakness (arms)
Tiredness
Paresthesia (legs)
Paresthesia (arms)
Dysesthesia
Burning feet
Pain:
feet
legs
arms
61 (47)
51 (39)
21 (16)
83 (63)
24 (18)
78 (60)
38 (29)
18 (14)
12 (9)
37 (28)
11 (8)
14 (11)
6 (5)
34 (53)
37 (58)
13 (20)
45 (70)
17 (26)
43 (67)
26 (40)
12 (19)
9 (14)
22 (34)
8 (12)
10 (16)
5 (8)
26 (39)
30 (45)
8 (12)
38 (58)
7 (11)
35 (53)
12(18)
6 (9)
4 (6)
14 (21)
3 (5)
4 (6)
1 (1)
ns
ns
ns
ns
ns
ns
<0.05
ns
ns
ns
ns
ns
ns
21 (37)
26 (46)
6 (10)
28 (49)
5 (9)
26 (36)
13 (23)
5 (9)
5 (9)
11 (19)
3 (5)
3 (5)
0 (0)
54(54)
57 (57)
20 (20)
74 (74)
20 (20)
70(70)
35 (35)
18 (18)
12 (12)
35(35)
11 (11)
15 (15)
8 (8)
<0.05
ns
ns
ns
ns
<0.05
ns
ns
ns
<0.05
ns
ns
<0.05
Clinical sign
Paresis
Stock area
Glove syndrome
Hypoesthesia (fingers)
Impaired vibratory perception:
great toe
middle of tibia
thumb
Abnormal reflexes:
Achilles
patellar
biceps
triceps
37 (28)
17 (13)
3 (2)
6 (5)
77 (59)
54 (41)
16 (12)
83 (63)
50 (49)
33 (25)
27 (21)
21 (33)
12 (19)
3 (4)
4 (6)
62 (55)
27 (42)
9 (14)
45 (70)
37 (58)
17 (27)
12 (19)
16 (24)
5 (7)
0 (0)
2 (3)
37 (56)
26 (39)
7 (10)
37 (56)
29 (44)
17 (26)
15 (23)
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
9 (16)
7 (12)
2 (3)
3 (5)
23 (40)
15 (26)
3 (5)
30 (53)
27 (47)
13 (23)
9 (16)
28 (38)
10 (13)
1 (1)
3 (4)
54 (73)
38 (51)
13 (18)
53 (72)
38 (51)
20 (27)
17 (23)
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
80% of the study group had clinically manifested neurop-
athy according to Nielsen’s criteria, only 7% had no
symptoms or clinical signs, and only 12% were without
clinical signs of neuropathy. Motor symptoms were more
common than sensory ones. In long-term dialysis pa-
tients, restless legs syndrome and cramps were the most
common neuropathy symptoms, whereas paresthesia and
burning feet syndrome were the most common sensory
symptoms (Table 2).
The most common clinical signs were abnormal Achil-
les reflex and impaired vibration sense, followed by pare-
sis of dorsiflexion of the great toe and stock area (Table
2). According to Nielsen’s criteria, 20% of the study pa-
tients had no clinically manifested uremic neuropathy,
39% had mild, and 41% moderate to severe neuropathy.
There was no statistically significant difference in the
prevalence of any symptom or clinical sign among dialy-
sis age subgroups, nor was any effect observed on the
clinical severity of uremic neuropathy according to Niel-
sen (p>0.05, Tables 3 and 4).
The following symptoms and clinical signs were more
common in the older subgroup: restless legs syndrome,
tiredness, burning feet syndrome, and pain (p<0.05), pa-
resis and atrophy of dorsiflexion of great toe (p<0.05),
and impaired vibration sense in the tarsal and tibial re-
gion (p<0.01). Older patients had a statistically signifi-
cantly higher rate of the severe forms of uremic neuropa-
thy than younger ones according to Nielsen (p<0.01)
(Table 4). There was no sex difference in any particular
symptom or sign except for paresthesia (p<0.05), and no
statistically significant difference in the clinical forms of
neuropathy according to Nielsen (p>0.05, Table 4).
Discussion
The symptoms and signs of uremic neuropathy are
very common in long-term hemodialysis patients. In our
patients, two motor symptoms were most common: cram-
ps and restless legs syndrome. Similar results have been
reported in the literature6, however, their importance in
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TABLE 3
EFFECT OF DIALYSIS AGE ON THE CLINICAL COURSE OF UREMIC NEUROPATHY
Symptoms and signs of neuropathy
Dialysis age (yrs)
<5
n=58 (%)
5–10
n=39 (%)
³ 10
n=34 (%)
Symptom
Restless legs
Cramps (legs)
Cramps (arms)
Muscular weakness (legs)
Muscular weakness (arms)
Tiredness
Paresthesia (legs)
Paresthesia (arms)
Dysesthesia
Burning feet
Pain
feet
legs
arms
26 (45)
28 (48)
12 (21)
36 (62)
12 (21)
38 (65)
18 (31)
6 (10)
5 (8)
19 (32)
5 (8)
6 (10)
2 (3)
17 (43)
22 (56)
3 (8)
28 (72)
5 (13)
26 (66)
11 (28)
7 (18)
6 (14)
8 (20)
5 (13)
5 (13)
3 (8)
18 (53)
18 (53)
6 (18)
19 (56)
6 (18)
14 (41)
10 (29)
5 (15)
2 (8)
10 (29)
1 (3)
3 (9)
1 (3)
Clinical sign
Paresis
Stock area
Glove syndrome
Hypoesthesia (fingers)
Impaired vibratory perception:
great toe
middle of tibia
thumb
Abnormal reflexes:
Achilles
patellar
biceps
triceps
16 (27)
6 (10)
1 (2)
1 (2)
33 (57)
25 (43)
11 (19)
33 (57)
24 (41)
14 (24)
11 (19)
10 (26)
8 (20)
0 (0)
1 (3)
23 (59)
15 (38)
5 (13)
24 (61)
19 (48)
9 (23)
9 (23)
11 (32)
3 (9)
2 (6)
4 (11)
21 (62)
13 (38)
0 (0)
26 (76)
22 (64)
11 (32)
7 (20)
the assessment of uremic neuropathy is not completely
clear because of unknown pathophysiological background.
Literature reports and our own experience indicate
that clonazepam is very effective in the management of
restless legs and cramps. It seems that these symptoms
may have a central origin. Muscle weakness in legs is also
a common symptom but is not specific enough. Pare-
sthesia and burning feet syndrome are the most common
sensory symptoms but their prevalence is considerably
lower than the prevalence of cramps and restless legs
syndrome. Paresthesia is an early symptom of uremic
neuropathy. It is believed to result from an early lesion of
peripheral nerve fiber. The prevalence of these symptoms
in different studies varies from 6% to 32%6,10–14. Late
sensory symptoms such as pain and dysesthesia have a
lower prevalence and often come in combination with
other symptoms and clinical signs of neuropathy. The
most common signs of uremic neuropathy in patients on
long-term hemodialysis are abnormal Achilles reflex
(motor sign) and impaired vibration sense on the pulp of
great toe (sensory sign). There is no clear predominance
of motor over sensory clinical signs of neuropathy. Pare-
sis of large toe dorsiflexion is the most frequent late clini-
cal sign. Sensory symptoms such as hypesthesia and
hypalgesia are less common. According to Nielsen’s crite-
ria, clinical signs are most important for clinical grading
of uremic neuropathy. There are great differences in the
frequency of clinical signs among different studies, rang-
ing from 11% to 75%4,6,14–18. Our study revealed a high
prevalence of the symptoms and clinical signs of neurop-
athy in hemodialysis patients, especially a higher fre-
quency of motor than sensory symptoms and clinical
signs. More than 80% of all study patients had clinically
manifested uremic neuropathy according to Nielsen. The
number of patients with mild, moderate and severe ure-
mic neuropathy was almost equal. There was no signifi-
cant effect of dialytic age on the clinical course of uremic
neuropathy. Unlike clinical course, there was evident
electrophysiological deterioration due to long-term he-
modialysis. Our previous electrophysiological study of
uremic neuropathy in long-term dialysis patients showed
the patients with more than 10 years of dialytic treat-
ment to have 11 of 16 electrophysiological parameters
tested significantly worsened as compared with a group
of patients with <5 years on hemodialysis (p<0.01). All
but one of these 11 parameters were related to moto-
ricity. The electrophysiological deterioration during long-
-term hemodialysis is best seen through worsening of the
H-wave of tibial and F-waves of peroneal and tibial
nerves19. The results of our study are consistent with
those reported by other authors who have demonstrated
that hemodialysis does not influence the clinical course
of uremic neuropathy, whereas electrophysiological find-
ings showed a tendency to worsening. However, most of
these studies considered only 1 to 2 years of hemo-
dialysis. Unlike dialytic age, there was a clear impact of
age on both the clinical course and electrophysiological
findings of uremic neuropathy. It seems that many of the
symptoms and signs are related to age. The clinical and
electrophysiological findings of uremic neuropathy sho-
wed no sex difference.
In conclusion, there is a high incidence of clinically
manifested uremic neuropathy in patients on long-term
hemodialysis. Prolonged hemodialytic treatment does not
influence the clinical course of uremic neuropathy but
leads to evident deterioration of electrophysiological fin-
dings. Older patients are burdened with more symptoms
and clinical signs, and have more severe forms of neurop-
athy than younger ones.
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TABLE 4
EFFECT OF PATIENT AGE ON THE CLINICAL COURSE OF
UREMIC NEUROPATHY ACCORDING TO NIELSEN
Clinical grade of neuropathy
after Nielsen
A B C
(n) (%) (n) (%) (n) (%)
Age
(yrs)
Younger (<53.2) 15 26 28 49 14 25
Older (³53.2) 10 14 27 36 37 50
c2-test, S=0.0093
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KLINI^KI TIJEK UREMI^KE NEUROPATIJE U BOLESNIKA NA DUGOTRAJNOJ HEMODIJALIZI
S A @ E T A K
U 131 bolesnika na dugotrajnoj hemodijalizi ispitivana je prisutnost klini~kih simptoma i znakova uremijske neuro-
patije kao i utjecaj dijalizne i `ivotne dobi te spola na istu. Prema du`ini dijalize bolesnici su podijeljeni u 3 podskupine:
kratka dijalizna dob, <5 godina dijalize (n=58); srednja dijalizna dob, 5–10 godina dijalize (n=39); visoka dijalizna dob,
>10 godina dijalize (n=34). U odnosu na srednju `ivotnu dob ispitanika koja je iznosila 53,2 godine, bolesnici su pod-
ijeljeni u dvije dobne skupine: mla|e (n=57) i starije (n=74). Klini~ko stupnjevanje uremijske neuropatije izvr{eno je
na temelju Nielsenovih kriterija. Naju~estaliji simptomi u bolesnika bili su sindrom nemirnih nogu (47%) i gr~evi (51%).
Senzori~ki poreme}aji imali su ni`u prevalenciju, a naj~e{}e su bile prisutne parestezije (29%) i sindrom u`arenih sto-
pala (28%). Promijenjen refleks Ahilove tetive (53%) i poreme}aj osjeta vibracije (59%) bili su naj~e{}i klini~ki znaci
neuropatije. Klini~ki manifestna uremijska neuropatija zabilje`ena je u 80% ispitanika: blaga forma u 41%, umjerena
do te{ka, prema Nielsenovim kriterijima, u 39% bolesnika. Nije zabilje`en jasan utjecaj dijalizne dobi i spola na klini~ki
tijek uremijske neuropatije, a evidentan je utjecaj `ivotne dobi. Mo`emo zaklju~iti da dugotrajna hemodijaliza ne utje~e
na klini~ki tijek uremijske neuropatije, dok je taj utjecaj jasan kod ispitivanja elektrofiziolo{kih parametara.
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